Table 1.
Multivariate analysis of the association between activation of the Fracture Prevention Service and pharmacological treatment for secondary prevention of fragility fractures at hospital discharge
Pharmacological secondary prevention
|
|||
---|---|---|---|
β | SE | P-value | |
Fracture unit | 0.34 | 0.04 | <0.0001 |
Age | −0.001 | 0.002 | 0.6875 |
Female sex | 0.14 | 0.05 | 0.0044 |
Specific treatment at admission | 0.44 | 0.07 | <0.0001 |
History of fracture | −0.13 | 0.04 | 0.0051 |
Abbreviation: SE, standard error.